Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- HELE +14.5%, SAR +10.3%, MYGN +2% (guidance), TSM +0.8% (Sep revs)
Other news:
- ALTM +31.1% (Arcadium Lithium to be acquired by Rio Tinto (RIO) for $5.85 per share)
- CLSD +25% (topline results from ODYSSEY phase 2b trial)
- ALAB +12.4% (announces new portfolio of fabric switches for AI workloads)
- NVX +7.7% (Novonix Limited and ICoNiChem to collaborate on sustainable cathode material feedstock)
- ZETA +3.6% (to acquire LiveIntent for $250 mln; also reaffirms Q3 guidance)
- SANA +2.9% (disclosed appointment of acting principal financial officer)
- SVM +2.2% (SGX Mine permit has been renewed for another 11 years)
- NVAX +1.9% (Updated 2024-2025 Nuvaxovid COVID-19 Vaccine Receives Authorization in the EU)
- VKTX +1.5% (Announces Results from Phase 1b Clinical Trial of VK0214 in Patients with X-ALD)
- WOR +1.4% (CEO to retire, promotes CFO Joseph Hayek to be next CEO; names Colin Souza as its new CFO)
- CSTL +1.3% (New Prospective, Multicenter Study Presented at SMR Demonstrates Castle Biosciences' DecisionDx-Melanoma Test Provides Significant Risk Prediction for Patients with Cutaneous Melanoma)
- SRFM +1.1% (Surf Air Mobility confirmed it issued to Palantir Technologies (PLTR) an aggregate of 1,270,869 shares of the Company's common stock for in-kind services worth $1.6 million)
- LEU +1% (wins award from US DoE)